Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mertelsmann

Showing results (151-160 of 366) with videos related to

Pageof 37
Sort By:
Hematology/Oncology Clinics of North America|October 1, 1991
Cytokines in the pathogenesis and management of non-Hodgkin's lymphomasN A Cicco, M Lübbert, W Oster, et al.
Leukemia|August 1, 1990
Splenic hematopoiesis following GM-CSF therapy in a patient with hairy cell leukemiaA Lindemann, F Herrmann, R Mertelsmann, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 15, 1995
[References for planning and implementation of clinical studies in somatic cell and gene therapy]A Lindemann, F M Rosenthal, S Hase, et al.
Current Opinion in Hematology|March 27, 1998
New developments in hematopoietic stem cell expansionC von Kalle, H Glimm, G Schulz, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Transfer RNA methyltransferases in different hemoblastoses]G Schöch, G Heller-Schöch, K Winkler, et al.
Cellular Immunology|July 1, 1983
Lymphokine factors inducing IgG production in human B-cell line ARH-77 and stimulatory effects of phorbol ester tumor promoterD H Maurer, K Welte, R Mertelsmann, et al.
Leukemia|September 1, 1993
The significance of serum levels of soluble 60kDa receptors for tumor necrosis factor in patients with Hodgkin's diseaseH J Gruss, G Dölken, M A Brach, et al.
Lancet (London, England)|October 17, 1992
High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's diseaseH J Gruss, G Dölken, M A Brach, et al.
Bone Marrow Transplantation|March 2, 1997
Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSFM Engelhardt, J Winkler, C Waller, et al.
Blood|November 1, 1991
Natural inhibitors of T-cell activation in Hodgkin's diseaseM Roux, B Schraven, A Roux, et al.
Pageof 37

Showing results (151-160 of 366) with videos related to

Sort By:
Pageof 37
Hematology/Oncology Clinics of North America|October 1, 1991
Cytokines in the pathogenesis and management of non-Hodgkin's lymphomasN A Cicco, M Lübbert, W Oster, et al.
Leukemia|August 1, 1990
Splenic hematopoiesis following GM-CSF therapy in a patient with hairy cell leukemiaA Lindemann, F Herrmann, R Mertelsmann, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 15, 1995
[References for planning and implementation of clinical studies in somatic cell and gene therapy]A Lindemann, F M Rosenthal, S Hase, et al.
Current Opinion in Hematology|March 27, 1998
New developments in hematopoietic stem cell expansionC von Kalle, H Glimm, G Schulz, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Transfer RNA methyltransferases in different hemoblastoses]G Schöch, G Heller-Schöch, K Winkler, et al.
Cellular Immunology|July 1, 1983
Lymphokine factors inducing IgG production in human B-cell line ARH-77 and stimulatory effects of phorbol ester tumor promoterD H Maurer, K Welte, R Mertelsmann, et al.
Leukemia|September 1, 1993
The significance of serum levels of soluble 60kDa receptors for tumor necrosis factor in patients with Hodgkin's diseaseH J Gruss, G Dölken, M A Brach, et al.
Lancet (London, England)|October 17, 1992
High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's diseaseH J Gruss, G Dölken, M A Brach, et al.
Bone Marrow Transplantation|March 2, 1997
Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSFM Engelhardt, J Winkler, C Waller, et al.
Blood|November 1, 1991
Natural inhibitors of T-cell activation in Hodgkin's diseaseM Roux, B Schraven, A Roux, et al.
Pageof 37